Annual Accounts Payable
$1.43 M
+$1.29 M+901.40%
December 31, 2023
Summary
- As of February 12, 2025, IMMX annual accounts payable is $1.43 million, with the most recent change of +$1.29 million (+901.40%) on December 31, 2023.
- During the last 3 years, IMMX annual accounts payable has risen by +$1.18 million (+467.97%).
- IMMX annual accounts payable is now at all-time high.
Performance
IMMX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.29 M
+$942.00 K+40.14%
September 30, 2024
Summary
- As of February 12, 2025, IMMX quarterly accounts payable is $3.29 million, with the most recent change of +$942.00 thousand (+40.14%) on September 30, 2024.
- IMMX quarterly accounts payable is now -6.39% below its all-time high of $3.51 million, reached on March 31, 2024.
Performance
IMMX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IMMX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +901.4% | - |
| 3 y3 years | +468.0% | - |
| 5 y5 years | +479.0% | - |
IMMX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +902.8% | -6.4% | +2201.3% |
| 5 y | 5-year | at high | +902.8% | -6.4% | +2201.3% |
| alltime | all time | at high | +902.8% | -6.4% | +2201.3% |
Immix Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.29 M(+40.1%) |
| Jun 2024 | - | $2.35 M(-33.2%) |
| Mar 2024 | - | $3.51 M(+145.2%) |
| Dec 2023 | $1.43 M(+901.4%) | $1.43 M(+901.4%) |
| Dec 2022 | $143.10 K | $143.10 K(-77.9%) |
| Sep 2022 | - | $646.50 K(-33.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $977.20 K(+219.7%) |
| Mar 2022 | - | $305.70 K(+113.9%) |
| Dec 2021 | $142.90 K(-43.4%) | $142.90 K(-76.9%) |
| Sep 2021 | - | $618.00 K(+238.1%) |
| Jun 2021 | - | $182.80 K(-27.5%) |
| Dec 2020 | $252.30 K(+1.9%) | $252.30 K |
| Dec 2019 | $247.50 K | - |
FAQ
- What is Immix Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Immix Biopharma?
- What is Immix Biopharma annual accounts payable year-on-year change?
- What is Immix Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Immix Biopharma?
What is Immix Biopharma annual accounts payable?
The current annual accounts payable of IMMX is $1.43 M
What is the all time high annual accounts payable for Immix Biopharma?
Immix Biopharma all-time high annual accounts payable is $1.43 M
What is Immix Biopharma annual accounts payable year-on-year change?
Over the past year, IMMX annual accounts payable has changed by +$1.29 M (+901.40%)
What is Immix Biopharma quarterly accounts payable?
The current quarterly accounts payable of IMMX is $3.29 M
What is the all time high quarterly accounts payable for Immix Biopharma?
Immix Biopharma all-time high quarterly accounts payable is $3.51 M